Filing Details
- Accession Number:
- 0001225208-24-006445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-30 16:27:23
- Reporting Period:
- 2024-05-29
- Accepted Time:
- 2024-05-30 16:27:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1566094 | B. Jeffrey Mirviss | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp&Pres, Periph Intervent | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-05-29 | 33,726 | $17.26 | 91,824 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-05-29 | 63,802 | $75.10 | 28,022 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-05-29 | 33,726 | $0.00 | 33,726 | $17.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-02-22 | No | 4 | M | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.78 to $75.33, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.